Senior Vice President and Managing Director, DIA EMEA
Dr. Holger G. Adelmann, MD PhD. Board certified Clinical Pharmacologist. Clinical training in internal medicine. Several leading positions in pharma since 1989 with Bayer & Tropon (Germany), AstraZeneca (UK and Sweden), and Merck Serono (Germany). He is member of the American Ass...
Read More →
Senior Director, Regulatory Affairs, Regulatory Intelligence, Mallinckrodt Pharmaceuticals
Kimberly (Kim) Belsky is a Sr. Director of Regulatory Intelligence at Mallinckrodt Pharmaceuticals. Prior to that, Kim was an Executive Director at OneSource Regulatory (OSR) and an Executive Director of AdPromo, Labeling, and Policy in Regulatory Affairs at Valeant Pharmaceutica...
Read More →
Consultant, Clinical Development, Blankstein Consulting Group
Dr. Larry Blankstein is an independent Senior Consultant to the Pharmaceutical and Biotechnology industry. He has over 22 years' experience in drug development strategy, clinical operations and mergers and acquisitions. He received his Ph.D. degree in Biology from Wesleyan Univer...
Read More →
Senior Vice President and Managing Director, DIA Americas, DIA
Director Pharmacovigilance, DADA Consultancy
PhD education level with accompanying communication skills, 10 years of experience in PV and 6 years of experience functioning as a QPPV, underwent and conducted 20 audits; fluid intelligence, quick thinking, helicopter view and focus for ensuring actions are set out and conducte...
Read More →
Assistant Professor, Clinical Pharmacy; Educational Liaison & Instructor, ICRS, University of Southern California
Dr. Smerkanich recently completed her doctorate in Regulatory Science on the Implementation of Benefit-Risk Frameworks in Industry. She leads the clinical regulatory courses while continuing to provide regulatory guidance to her academic and industry peers. In her new role at USC...
Read More →
